Insider Buying: President, CEO & Chairman, 10% Owner ROSENWALD LINDSAY A MD Acquires 50,000 ...
On January 5, 2024, ROSENWALD LINDSAY A MD, the President, CEO & Chairman, and 10% Owner of Fortress Biotech Inc, executed a significant stock purchase, acquiring 50,000 shares of the company. This transaction was filed with the SEC and can be found in detail through the following SEC Filing.
Fortress Biotech Inc, traded under the ticker FBIO, is a biopharmaceutical company that is involved in the development and commercialization of pharmaceutical and biotechnology products. The company's business strategy includes partnering with biotech and pharmaceutical companies to help bring their products to market.
Insider transactions are closely monitored as they can provide insights into a company's financial health and future prospects. An insider purchase can suggest that the insider believes the stock is undervalued or that there are positive developments ahead for the company.
Over the past year, the insider has purchased a total of 1,717,515 shares and has not sold any shares. This latest acquisition continues the trend of insider buying activity for the company.
The insider transaction history for Fortress Biotech Inc shows a pattern of insider confidence, with 4 insider buys and 0 insider sells over the past year.
On the date of the insider's recent purchase, shares of Fortress Biotech Inc were trading at $2.38, resulting in a market cap of $42.305 million.
The stock's price-to-GF-Value ratio stands at 0.22, with a GuruFocus Value of $10.79. This valuation suggests that the stock may be categorized as a Possible Value Trap, Think Twice, according to its GF Value.
The GF Value is determined by considering historical trading multiples, a GuruFocus adjustment factor based on the company's historical returns and growth, and future business performance estimates provided by Morningstar analysts.
The GF Value for Fortress Biotech Inc indicates that the stock is trading significantly below its intrinsic value, which may attract investors looking for potential undervalued opportunities.
Investors and analysts will continue to watch insider transaction trends and the stock's valuation metrics to gauge the potential direction of Fortress Biotech Inc's share price.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
